These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8666938)

  • 21. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
    Foley BA; De Santis D; Van Beelen E; Lathbury LJ; Christiansen FT; Witt CS
    Blood; 2008 Jul; 112(2):435-43. PubMed ID: 18385451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
    Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
    PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
    Carr WH; Pando MJ; Parham P
    J Immunol; 2005 Oct; 175(8):5222-9. PubMed ID: 16210627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
    Bonaparte MI; Barker E
    Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
    Stern M; Ruggeri L; Capanni M; Mancusi A; Velardi A
    Blood; 2008 Aug; 112(3):708-10. PubMed ID: 18502829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
    Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
    J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.
    Frohn C; Schlenke P; Kirchner H
    Immunology; 1997 Dec; 92(4):567-70. PubMed ID: 9497500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles.
    D'Andrea A; Chang C; Phillips JH; Lanier LL
    J Exp Med; 1996 Aug; 184(2):789-94. PubMed ID: 8760835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKB1: a killer cell inhibitory receptor for class I HLA-B allotypes.
    D'Andrea A; Lanier LL
    Chem Immunol; 1996; 64():104-15. PubMed ID: 8942075
    [No Abstract]   [Full Text] [Related]  

  • 32. NK cells become Ki-67+ in MLC and expand depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLC.
    Grzywacz B; Dlubek D; Lange A
    Hum Immunol; 2002 Aug; 63(8):638-46. PubMed ID: 12121671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas-independent apoptosis of T cells via killer cell inhibitory receptors.
    Nakajima H; Yamada N; Takiguchi M
    Int Immunol; 1998 Jan; 10(1):85-90. PubMed ID: 9488158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
    Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.